News

Mallinckrodt To Present Data On TERLIVAZ® (Terlipressin) For Injection At The 2025 Digestive Disease Week (DDW) Annual Meeting
Five presentations highlight TERLIVAZ research in adults with HRS with rapid reduction in kidney function,1 also known as HRS-AKI<sup ...
Commercial Integrator1d
AVI Systems Rebrands as FORTÉ
FORTÉ, the new brand identity of AVI Systems, is dedicated to innovation, collaboration and transforming the modern workplace ...
Akari Therapeutics Releases Welcome Video from Newly Appointed Chief Executive Officer, Abizer Gaslightwala
Biotechnology and pharmaceutical industry veteran, Abizer Gaslightwala, shares his vision for Akari moving forwardAccess the video hereBOSTON and ...
Le Lézard1d
Hybrid Product Portfolio of OEMs worth 28.5 million units by 2030 | MarketsandMarkets
The hybrid market is projected to grow from 12.4 million units in 2024 to 28.5 million units by 2030, at a CAGR of 15.0%., according to a new report by MarketsandMarkets. The hybrid market is ...
Shareholders that lost money on Actinium Pharmaceuticals, Inc.(ATNM) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
NEW YORK, NY / ACCESS Newswire / April 20, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want ...
CalciMedica Announces Presentations at Upcoming Medical Meetings
CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition ...